Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Corvidane logo — A novel approach to treating cardiovascular and liver diseas...

Corvidane

A novel approach to treating cardiovascular and liver diseases

Founded 2014 The Netherlands The Netherlands 4 employees Health and Wellness, Manufacturing +1

General Information

Company Name Corvidane
Founded Year 2014
Location The Netherlands The Netherlands +2
Founders / Decision Makers
Team member Team member
Employees 4
Industries Health and Wellness, Manufacturing, Pharmaceutical
Social

Get notified when Corvidane moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Corvidane

Corvidane is a biotech startup with a novel approach to treating cardiovascular and liver diseases. Founded in 2014, the company is focused on developing Corvida™ for the treatment of atherosclerosis and metabolic associated fatty liver disease (MASH). Corvidane's innovative approach targets atherosclerotic plaques, addressing a major factor in heart attacks and strokes. Additionally, their development of a treatment for MASH, a leading cause of liver transplants in the United States, showcases their potential impact in the field of liver disease treatment. The company operates in the manufacturing and pharmaceutical industries, positioning itself at the intersection of medical innovation and production. With a slogan emphasizing their distinctive approach, Corvidane's focus on metabolic and inflammatory diseases sets them apart in the biotech landscape. Despite the absence of specific headquarters and recent investment details, Corvidane's pioneering solutions in treating challenging diseases make them a compelling prospect for venture capitalists seeking opportunities in the healthcare sector.

Taxonomy: cardiovascular diseases, liver diseases, metabolic diseases, inflammatory diseases, atherosclerosis, MASH, drug development, biopharmaceutical, oral medications, treatment therapies, innovative treatments, pharmaceutical research, medical innovation, healthcare advancements

No funding data available for Corvidane yet.

Get notified when Corvidane raises funding

Corvidane Alternatives & Competitors

Corvidane vs
Immunic Therapeutics
Immunic Therapeutics United States

Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and...

Post Ipo Equity
91 employees
Biotechnology, Health and Wellness
Corvidane vs
ActoGeniX N.V.
ActoGeniX N.V. Belgium

ActoGeniX is a biopharmaceutical company, focused on the development and commercialization of a new...

Private Equity
5 employees
Biopharma, Biotechnology
Corvidane vs
LPOXY Therapeutics, Inc.
LPOXY Therapeutics, Inc. United States

First-ever C. difficile protection for the billions of patients on antibiotic therapy.

1 employees
Health Care

FAQ About Corvidane

A novel approach to treating cardiovascular and liver diseases
Corvidane was founded in 2014.
Corvidane is headquartered in The Netherlands.
Corvidane operates in the following industries: Health and Wellness, Manufacturing, Pharmaceutical.
Corvidane has approximately 4 employees.
Top alternatives and competitors to Corvidane include Immunic Therapeutics, ActoGeniX N.V., LPOXY Therapeutics, Inc., Tricida, Inc., Vandria SA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Corvidane and Immunic Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Corvidane and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy